COMBINED PULMONARY FIBROSIS AND EMPHYSEMA

This adverse event was reported 71 times

These drugs are most commonly taken by patients reporting COMBINED PULMONARY FIBROSIS AND EMPHYSEMA:

# Drug Count
0 TREPROSTINIL 17
1 METHOTREXATE SODIUM 10
2 APIXABAN 9
3 METHOTREXATE 8
4 NINTEDANIB 8
5 0XYGEN 7
6 ASPIRIN 7
7 FOLIC ACID 7
8 MACITENTAN 7
9 OXYGEN 7
See all common drugs associated with COMBINED PULMONARY FIBROSIS AND EMPHYSEMA

COMBINED PULMONARY FIBROSIS AND EMPHYSEMA is most prevalent among patients taking these drugs:

# Drug Count Frequency
0 VADADUSTAT 1 0.0033
1 NALDEMEDINE 2 0.0012
2 LEMBOREXANT 2 0.0007
3 ISAVUCONAZONIUM SULFATE 2 0.0005
4 LUSPATERCEPT 1 0.0004
5 FEBUXOSTAT TABLETS 40 MG 3 0.0003
6 NINTEDANIB 8 0.0002
7 DOLUTEGRAVIR SODIUM 2 0.0002
8 ACITRETIN 1 0.0002
9 PITAVASTATIN CALCIUM 2 0.0002
See all drugs enriched for association with COMBINED PULMONARY FIBROSIS AND EMPHYSEMA